Dixon Technologies meets SBI Funds, Motilal Oswal on June 9

Dixon Technologies (India) Limited conducted meetings with institutional investors SBI Funds Management Pvt. Ltd. and Motilal Oswal Asset Management Company Limited on June 9, 2026. The company confirmed that no unpublished price sensitive information was shared during these interactions, which were held pursuant to Regulations 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The meetings were organized as one-on-one sessions and took place in-person. The first meeting with SBI Funds Management Pvt. Ltd. was scheduled at 10:00 A.M., followed by a session with Motilal Oswal Asset Management Company Limited at 11:00 A.M. on the same day.

Meeting Details

Name of the Fund/analyst/Institutional Investor/ Broker etc. including prospective Investor	Date of Meeting(s)	Time (IST)	Mode of Meeting(s)	Type of Meeting(s)
SBI Funds Management Pvt. Ltd.	9 June, 2026	10:00 A.M.	In-Person	One-on-One
Motilal Oswal Asset Management Company Limited	9 June, 2026	11:00 A.M.	In-Person	One-on-One

The disclosure was submitted to the stock exchanges to inform stakeholders about the investor engagement activities. No presentations were made during the aforesaid meetings.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.54%	+0.50%	+7.19%	-11.10%	-21.93%	+175.59%

Dixon Technologies is awaiting government approval for its proposed joint venture with smartphone maker Vivo, with the company expressing hope that the clearance will come through soon. The matter is currently pending with the relevant government authorities, according to a report by CNBCTV18.

Approval Status

The key details surrounding the pending joint venture approval are as follows:

Parameter:	Details
Joint Venture:	Dixon Technologies & Vivo
Approval Status:	Pending with Government
Company Outlook:	Hopeful of receiving approval soon
Source:	CNBCTV18

Awaiting Regulatory Clearance

Dixon Technologies has indicated that it remains hopeful of securing the necessary government approval for the Vivo joint venture in the near term. The company has not provided additional details regarding the timeline or the specific regulatory body handling the approval process. No financial terms or operational specifics of the joint venture have been disclosed in the available information.